Molecular insights into mineralotropic hormone inter-regulation

The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ). Early research efforts focused on PTH and 1,25(OH) 2 D 3 and more recently on FGF23 have revealed that each of these hormones regulates the expression of the o...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 14; p. 1213361
Main Authors Pike, J. Wesley, Lee, Seong Min, Meyer, Mark B.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.06.2023
Subjects
Online AccessGet full text
ISSN1664-2392
1664-2392
DOI10.3389/fendo.2023.1213361

Cover

Abstract The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ). Early research efforts focused on PTH and 1,25(OH) 2 D 3 and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH) 2 D 3 and FGF23; the regulation of PTH by 1,25(OH) 2 D 3 , however, remains obscure. We review here our molecular understanding of how PTH induces Cyp27b1 expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH) 2 D 3 . FGF23 and 1,25(OH) 2 D 3 , on the other hand, function by suppressing production of 1,25(OH) 2 D 3 . PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of Cyp27b1 . PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied Cyp27b1 sites. The negative actions of both FGF23 and 1,25(OH) 2 D 3 appear to suppress Cyp27b1 expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at Cyp24a1 , the gene encoding the enzyme that degrades 1,25(OH) 2 D 3 , thereby contributing to the overall regulation of blood levels of 1,25(OH) 2 D 3 . Relative to PTH regulation, we summarize what is known of how 1,25(OH) 2 D 3 regulates PTH suppression. These studies suggest that it is not 1,25(OH) 2 D 3 that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an in vivo approach that furthers our understanding of the regulation of Fgf23 expression by PTH and 1,25(OH) 2 D 3 and provide the first evidence that P may act to induce Fgf23 expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes.
AbstractList The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). Early research efforts focused on PTH and 1,25(OH)2D3 and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH)2D3 and FGF23; the regulation of PTH by 1,25(OH)2D3, however, remains obscure. We review here our molecular understanding of how PTH induces Cyp27b1 expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH)2D3. FGF23 and 1,25(OH)2D3, on the other hand, function by suppressing production of 1,25(OH)2D3. PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of Cyp27b1. PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied Cyp27b1 sites. The negative actions of both FGF23 and 1,25(OH)2D3 appear to suppress Cyp27b1 expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at Cyp24a1, the gene encoding the enzyme that degrades 1,25(OH)2D3, thereby contributing to the overall regulation of blood levels of 1,25(OH)2D3. Relative to PTH regulation, we summarize what is known of how 1,25(OH)2D3 regulates PTH suppression. These studies suggest that it is not 1,25(OH)2D3 that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an in vivo approach that furthers our understanding of the regulation of Fgf23 expression by PTH and 1,25(OH)2D3 and provide the first evidence that P may act to induce Fgf23 expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes.
The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ). Early research efforts focused on PTH and 1,25(OH) 2 D 3 and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH) 2 D 3 and FGF23; the regulation of PTH by 1,25(OH) 2 D 3 , however, remains obscure. We review here our molecular understanding of how PTH induces Cyp27b1 expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH) 2 D 3 . FGF23 and 1,25(OH) 2 D 3 , on the other hand, function by suppressing production of 1,25(OH) 2 D 3 . PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of Cyp27b1 . PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied Cyp27b1 sites. The negative actions of both FGF23 and 1,25(OH) 2 D 3 appear to suppress Cyp27b1 expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at Cyp24a1 , the gene encoding the enzyme that degrades 1,25(OH) 2 D 3 , thereby contributing to the overall regulation of blood levels of 1,25(OH) 2 D 3 . Relative to PTH regulation, we summarize what is known of how 1,25(OH) 2 D 3 regulates PTH suppression. These studies suggest that it is not 1,25(OH) 2 D 3 that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an in vivo approach that furthers our understanding of the regulation of Fgf23 expression by PTH and 1,25(OH) 2 D 3 and provide the first evidence that P may act to induce Fgf23 expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes.
The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D (1,25(OH) D ). Early research efforts focused on PTH and 1,25(OH) D and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH) D and FGF23; the regulation of PTH by 1,25(OH) D , however, remains obscure. We review here our molecular understanding of how PTH induces expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH) D . FGF23 and 1,25(OH) D , on the other hand, function by suppressing production of 1,25(OH) D . PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of . PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied sites. The negative actions of both FGF23 and 1,25(OH) D appear to suppress expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at , the gene encoding the enzyme that degrades 1,25(OH) D , thereby contributing to the overall regulation of blood levels of 1,25(OH) D . Relative to PTH regulation, we summarize what is known of how 1,25(OH) D regulates PTH suppression. These studies suggest that it is not 1,25(OH) D that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an approach that furthers our understanding of the regulation of expression by PTH and 1,25(OH) D and provide the first evidence that P may act to induce expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes.
The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). Early research efforts focused on PTH and 1,25(OH)2D3 and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH)2D3 and FGF23; the regulation of PTH by 1,25(OH)2D3, however, remains obscure. We review here our molecular understanding of how PTH induces Cyp27b1 expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH)2D3. FGF23 and 1,25(OH)2D3, on the other hand, function by suppressing production of 1,25(OH)2D3. PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of Cyp27b1. PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied Cyp27b1 sites. The negative actions of both FGF23 and 1,25(OH)2D3 appear to suppress Cyp27b1 expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at Cyp24a1, the gene encoding the enzyme that degrades 1,25(OH)2D3, thereby contributing to the overall regulation of blood levels of 1,25(OH)2D3. Relative to PTH regulation, we summarize what is known of how 1,25(OH)2D3 regulates PTH suppression. These studies suggest that it is not 1,25(OH)2D3 that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an in vivo approach that furthers our understanding of the regulation of Fgf23 expression by PTH and 1,25(OH)2D3 and provide the first evidence that P may act to induce Fgf23 expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes.The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). Early research efforts focused on PTH and 1,25(OH)2D3 and more recently on FGF23 have revealed that each of these hormones regulates the expression of the other two. Despite early suggestions of transcriptional processes, it has been only recently that research effort have begun to delineate the genomic mechanisms underpinning this regulation for 1,25(OH)2D3 and FGF23; the regulation of PTH by 1,25(OH)2D3, however, remains obscure. We review here our molecular understanding of how PTH induces Cyp27b1 expression, the gene encoding the enzyme responsible for the synthesis of 1,25(OH)2D3. FGF23 and 1,25(OH)2D3, on the other hand, function by suppressing production of 1,25(OH)2D3. PTH stimulates the PKA-induced recruitment of CREB and its coactivator CBP at CREB occupied sites within the kidney-specific regulatory regions of Cyp27b1. PKA activation also promotes the nuclear translocation of SIK bound coactivators such as CRTC2, where it similarly interacts with CREB occupied Cyp27b1 sites. The negative actions of both FGF23 and 1,25(OH)2D3 appear to suppress Cyp27b1 expression by opposing the recruitment of CREB coactivators at this gene. Reciprocal gene actions are seen at Cyp24a1, the gene encoding the enzyme that degrades 1,25(OH)2D3, thereby contributing to the overall regulation of blood levels of 1,25(OH)2D3. Relative to PTH regulation, we summarize what is known of how 1,25(OH)2D3 regulates PTH suppression. These studies suggest that it is not 1,25(OH)2D3 that controls PTH levels in healthy subjects, but rather calcium itself. Finally, we describe current progress using an in vivo approach that furthers our understanding of the regulation of Fgf23 expression by PTH and 1,25(OH)2D3 and provide the first evidence that P may act to induce Fgf23 expression via a complex transcriptional mechanism in bone. It is clear, however, that additional advances will need to be made to further our understanding of the inter-regulation of each of these hormonal genes.
Author Pike, J. Wesley
Meyer, Mark B.
Lee, Seong Min
AuthorAffiliation 2 Department of Nutritional Sciences, University of Wisconsin-Madison , Madison, WI , United States
1 Department of Biochemistry, University of Wisconsin-Madison , Madison, WI , United States
AuthorAffiliation_xml – name: 2 Department of Nutritional Sciences, University of Wisconsin-Madison , Madison, WI , United States
– name: 1 Department of Biochemistry, University of Wisconsin-Madison , Madison, WI , United States
Author_xml – sequence: 1
  givenname: J. Wesley
  surname: Pike
  fullname: Pike, J. Wesley
– sequence: 2
  givenname: Seong Min
  surname: Lee
  fullname: Lee, Seong Min
– sequence: 3
  givenname: Mark B.
  surname: Meyer
  fullname: Meyer, Mark B.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37441497$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtv1DAQtlARLaV_gAPaI5csHo83iU8VqnhUKuICZ8uxJ7uuEnuxvUj993gfRS0HfJmR53t4_L1mZyEGYuwt8CVirz6MFFxcCi5wCQIQW3jBLqBtZSNQibMn_Tm7yvme1yM5KNW_YufYSQlSdRfs-lucyO4mkxY-ZL_elFybEhezD5TMFEuKW28Xm5jm-oD9jFKTaF0pxcfwhr0czZTp6lQv2c_Pn37cfG3uvn-5vfl411jZqtIYRWTEsFoJaVeqswCShlrR9KYdrKKBdyNaQw4kV2DcYCQ53ptR8tYpxEt2e9R10dzrbfKzSQ86Gq8PFzGttUnF24k0txIliBZd3dgqGDhXCtpudJ1R4GTVuj5qbXfDTM5SKHXTZ6LPJ8Fv9Dr-1sARpQCoCu9PCin-2lEuevbZ0jSZQHGXteixFxKBryr03VOzvy6PEVRAfwTYFHNONGrry-Fvq7efqqneB64Pget94PoUeKWKf6iP6v8h_QH-orBH
CitedBy_id crossref_primary_10_3390_biom14060717
crossref_primary_10_3177_jnsv_70_82
crossref_primary_10_1007_s13105_025_01072_z
Cites_doi 10.1007/s00198-005-0036-3
10.1073/pnas.241516798
10.1152/ajpgi.00243.2005
10.1016/j.jsbmb.2013.09.005
10.1371/journal.pone.0214349
10.1073/pnas.91.3.900
10.1074/jbc.270.4.1675
10.1038/355446a0
10.1097/MNH.0000000000000467
10.1172/JCI19081
10.1194/jlr.R031534
10.1093/ajcn/80.6.1689S
10.1359/JBMR.0301264
10.1371/journal.pone.0142924
10.1101/gad.14.13.1553
10.1073/pnas.82.12.4270
10.1016/j.jbc.2022.102559
10.1038/ki.2014.215
10.1016/S0960-0760(98)00055-7
10.1073/pnas.101545198
10.1038/nature11212
10.1073/pnas.87.24.9751
10.1073/pnas.89.17.8097
10.1152/ajprenal.00360.2010
10.1002/jbm4.10023
10.1152/ajpendo.00557.2012
10.1681/ASN.2005111185
10.1074/jbc.RA119.010173
10.1172/JCI164610
10.1016/j.abb.2011.11.003
10.1210/me.2014-1091
10.1016/j.clinthera.2019.09.009
10.1002/jbmr.2417
10.1210/me.2011-1149
10.1152/ajprenal.00360.2009
10.1006/abbi.2000.1964
10.1152/ajpendo.1984.246.2.E168
10.1093/ndt/17.suppl_10.10
10.1210/en.2019-00622
10.1186/gb-2012-13-8-418
10.1152/ajprenal.00474.2004
10.1016/j.jsbmb.2010.02.011
10.1016/j.molmet.2018.02.007
10.1002/jbm4.10432
10.1038/nrd3318
10.1074/jbc.M110.119958
10.1074/jbc.RA119.008760
10.1074/jbc.M114.578104
10.1371/journal.pone.0072816
10.1016/j.bone.2015.03.012
10.1359/JBMR.041227
10.1530/JOE-15-0225
10.1172/JCI131190
10.1016/j.jsbmb.2006.12.020
10.1152/physrev.2001.81.1.239
10.1016/j.jsbmb.2015.09.001
10.1128/MCB.00200-19
10.1002/jbm4.10433
10.1172/JCI163627
10.1074/jbc.271.48.30381
10.1038/nature11232
10.1002/jbmr.3609
10.1093/ndt/gft065
10.1074/jbc.M117.806901
10.1172/JCI112714
10.1016/j.jsbmb.2013.11.004
ContentType Journal Article
Copyright Copyright © 2023 Pike, Lee and Meyer.
Copyright © 2023 Pike, Lee and Meyer 2023 Pike, Lee and Meyer
Copyright_xml – notice: Copyright © 2023 Pike, Lee and Meyer.
– notice: Copyright © 2023 Pike, Lee and Meyer 2023 Pike, Lee and Meyer
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fendo.2023.1213361
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2392
ExternalDocumentID oai_doaj_org_article_0c4341263d004c91b0099167fd7a91d4
PMC10334211
37441497
10_3389_fendo_2023_1213361
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL159645
– fundername: NIDDK NIH HHS
  grantid: R01 DK117475
– fundername: NCI NIH HHS
  grantid: P30 CA014520
– fundername: NIAMS NIH HHS
  grantid: R01 AR064424
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c469t-a9eea2b5524c597c114eb97c3a8a6bc9eb07f3caed14091adba4ed08af406d933
IEDL.DBID M48
ISSN 1664-2392
IngestDate Wed Aug 27 01:23:19 EDT 2025
Thu Aug 21 18:36:56 EDT 2025
Thu Sep 04 18:43:27 EDT 2025
Thu Jul 24 02:16:30 EDT 2025
Thu Apr 24 23:03:47 EDT 2025
Tue Jul 01 01:41:43 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords CRISPR/Cas9
transcription
PTH gene
mutant mice
FGF23 gene
Cyp27b1/Cyp24a1 genes
ChIP-seq analysis
mineral regulating hormones
Language English
License Copyright © 2023 Pike, Lee and Meyer.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-a9eea2b5524c597c114eb97c3a8a6bc9eb07f3caed14091adba4ed08af406d933
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Rik Mencke, University Medical Center Groningen, Netherlands
Reviewed by: Sylvia Christakos, Rutgers, The State University of New Jersey, United States; Adriana Dusso, Washington University in St. Louis, United States
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fendo.2023.1213361
PMID 37441497
PQID 2838243105
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_0c4341263d004c91b0099167fd7a91d4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10334211
proquest_miscellaneous_2838243105
pubmed_primary_37441497
crossref_citationtrail_10_3389_fendo_2023_1213361
crossref_primary_10_3389_fendo_2023_1213361
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-27
PublicationDateYYYYMMDD 2023-06-27
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-27
  day: 27
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in endocrinology (Lausanne)
PublicationTitleAlternate Front Endocrinol (Lausanne)
PublicationYear 2023
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Onal (B12) 2015; 30
Meyer (B20) 2022; 298
Kolek (B56) 2005; 289
Zierold (B40) 1995; 270
Haussler (B15) 2021; 5
Brown (B53) 2001; 81
Shimada (B30) 2004; 113
Goodman (B24) 2000; 14
Kovesdy (B34) 2013; 28
Pike (B2) 2021; 5
Yoon (B23) 2023; 133
Liao (B7) 1990; 87
Tanaka (B28) 1984; 246
Plum (B46) 2010; 9
Kaneko (B57) 2015; 226
Russell (B42) 1984; 97
Meyer (B14) 2016; 164
Quarles (B33) 2019; 28
Zierold (B25) 2001; 98
Lee (B68) 2022
Neph (B4) 2012; 489
Stamatoyannopoulos (B22) 2012; 13
Shimada (B29) 2004; 19
Lavi-Moshayoff (B54) 2010; 299
St John (B66) 2014; 28
Bon (B64) 2018; 11
Jones (B17) 2012; 523
Pike (B67) 2015; 81
Zhou (B62) 2023; 133
Silver (B43) 1985; 82
Onal (B65) 2018; 2
Lee (B60) 2019; 160
Schuster (B50) 2019; 41
Zierold (B39) 1994; 91
Ozono (B37) 1998; 66
Ohyama (B38) 1996; 271
Couasnay (B63) 2019; 34
Thurman (B3) 2012; 489
Ahmed (B49) 2019; 14
Quinn (B18) 2013; 304
Simic (B61) 2020; 130
Meyer (B27) 2019; 294
Demay (B51) 1992; 89
Meyer (B21) 2019; 294
Bell (B45) 2005; 20
Chanakul (B36) 2013; 8
Jones (B16) 2014; 55
Kliewer (B8) 1992; 355
Meir (B59) 2014; 86
Shimada (B31) 2005; 289
Portale (B35) 2015; 10
Silver (B44) 1986; 78
Kim (B11) 2007; 103
Meyer (B19) 2017; 292
Plum (B47) 2006; 17
Brown (B48) 2002
Meyer (B5) 2010; 121
Van de Velde (B32) 2019; 39
Liu (B58) 2006; 17
Pike (B6) 2014
Shimada (B55) 2001; 98
Onal (B13) 2012; 26
Meyer (B9) 2014; 289
Meyer (B41) 2010; 285
DeLuca (B1) 2004; 80
Zierold (B26) 2000; 381
Meyer (B10) 2014
Meir (B52) 2009; 297
References_xml – volume: 17
  year: 2006
  ident: B47
  article-title: 2MD, a new anabolic agent for osteoporosis treatment
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-005-0036-3
– volume: 98
  year: 2001
  ident: B25
  article-title: Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability
  publication-title: Proc Natl Acad Sci U.S.A.
  doi: 10.1073/pnas.241516798
– volume: 289
  year: 2005
  ident: B56
  article-title: 1alpha,25-dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00243.2005
– start-page: 19
  year: 2014
  ident: B10
  article-title: 1,25-dihydroxyvitamin D3 induced histone profiles guide discovery of VDR action sites
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2013.09.005
– volume: 14
  year: 2019
  ident: B49
  article-title: Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and bcl-2 in STZ-induced diabetic rats
  publication-title: PloS One
  doi: 10.1371/journal.pone.0214349
– volume: 91
  year: 1994
  ident: B39
  article-title: Identification of a vitamin d-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene
  publication-title: Proc Natl Acad Sci U.S.A.
  doi: 10.1073/pnas.91.3.900
– volume: 270
  year: 1995
  ident: B40
  article-title: Two vitamin d response elements function in the rat 1,25-dihydroxyvitamin d 24-hydroxylase promoter
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.4.1675
– volume: 355
  year: 1992
  ident: B8
  article-title: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling
  publication-title: Nature
  doi: 10.1038/355446a0
– volume: 28
  start-page: 16
  year: 2019
  ident: B33
  article-title: Fibroblast growth factor 23 and α-klotho co-dependent and independent functions
  publication-title: Curr Opin Nephrol Hypertens
  doi: 10.1097/MNH.0000000000000467
– volume: 113
  year: 2004
  ident: B30
  article-title: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin d metabolism
  publication-title: J Clin Invest
  doi: 10.1172/JCI19081
– volume: 55
  start-page: 13
  year: 2014
  ident: B16
  article-title: Cytochrome P450-mediated metabolism of vitamin d
  publication-title: J Lipid Res
  doi: 10.1194/jlr.R031534
– volume: 80
  year: 2004
  ident: B1
  article-title: Overview of general physiologic features and functions of vitamin d
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/80.6.1689S
– volume: 19
  year: 2004
  ident: B29
  article-title: FGF-23 is a potent regulator of vitamin d metabolism and phosphate homeostasis
  publication-title: J Bone Miner Res
  doi: 10.1359/JBMR.0301264
– volume: 10
  year: 2015
  ident: B35
  article-title: Characterization of FGF23-dependent egr-1 cistrome in the mouse renal proximal tubule
  publication-title: PloS One
  doi: 10.1371/journal.pone.0142924
– volume: 14
  year: 2000
  ident: B24
  article-title: CBP/p300 in cell growth, transformation, and development
  publication-title: Genes Dev
  doi: 10.1101/gad.14.13.1553
– volume: 82
  year: 1985
  ident: B43
  article-title: Regulation by vitamin d metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells
  publication-title: Proc Natl Acad Sci U.S.A.
  doi: 10.1073/pnas.82.12.4270
– volume: 298
  year: 2022
  ident: B20
  article-title: Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules
  publication-title: J Biol Chem
  doi: 10.1016/j.jbc.2022.102559
– volume: 86
  year: 2014
  ident: B59
  article-title: Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription
  publication-title: Kidney Int
  doi: 10.1038/ki.2014.215
– volume: 66
  year: 1998
  ident: B37
  article-title: Direct repeat 3-type element lacking the ability to bind to the vitamin d receptor enhances the function of a vitamin d-responsive element
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/S0960-0760(98)00055-7
– volume: 98
  year: 2001
  ident: B55
  article-title: Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
  publication-title: Proc Natl Acad Sci U.S.A.
  doi: 10.1073/pnas.101545198
– volume: 489
  start-page: 83
  year: 2012
  ident: B4
  article-title: An expansive human regulatory lexicon encoded in transcription factor footprints
  publication-title: Nature
  doi: 10.1038/nature11212
– volume: 87
  year: 1990
  ident: B7
  article-title: Vitamin d receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3
  publication-title: Proc Natl Acad Sci U.S.A.
  doi: 10.1073/pnas.87.24.9751
– volume: 89
  year: 1992
  ident: B51
  article-title: Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3
  publication-title: Proc Natl Acad Sci U.S.A.
  doi: 10.1073/pnas.89.17.8097
– volume: 299
  year: 2010
  ident: B54
  article-title: PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00360.2010
– volume: 2
  start-page: 32
  year: 2018
  ident: B65
  article-title: A novel distal enhancer mediates inflammation-, PTH-, and early onset murine kidney disease-induced expression of the mouse Fgf23 gene
  publication-title: JBMR Plus
  doi: 10.1002/jbm4.10023
– volume: 304
  year: 2013
  ident: B18
  article-title: CaSR-mediated interactions between calcium and magnesium homeostasis in mice
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00557.2012
– volume: 97
  start-page: 296
  year: 1984
  ident: B42
  article-title: The effects of calcium and vitamin d metabolites on cytoplasmic mRNA coding for pre-proparathyroid hormone in isolated parathyroid cells
  publication-title: Trans Assoc Am Physicians
– volume: 17
  year: 2006
  ident: B58
  article-title: Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin d
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2005111185
– volume: 294
  year: 2019
  ident: B27
  article-title: A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and nonrenal tissues
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA119.010173
– volume: 133
  year: 2023
  ident: B62
  article-title: Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis
  publication-title: J Clin Invest
  doi: 10.1172/JCI164610
– volume: 523
  start-page: 9
  year: 2012
  ident: B17
  article-title: 25-hydroxyvitamin d-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin d
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2011.11.003
– volume: 28
  year: 2014
  ident: B66
  article-title: The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2014-1091
– volume: 41
  year: 2019
  ident: B50
  article-title: Use of paricalcitol as adjunctive therapy to renin-Angiotensin-Aldosterone system inhibition for diabetic nephropathy: a systematic review of the literature
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2019.09.009
– volume: 30
  year: 2015
  ident: B12
  article-title: A DNA segment spanning the mouse Tnfsf11 transcription unit and its upstream regulatory domain rescues the pleiotropic biologic phenotype of the RANKL null mouse
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.2417
– volume: 26
  year: 2012
  ident: B13
  article-title: The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2011-1149
– volume: 297
  year: 2009
  ident: B52
  article-title: Deletion of the vitamin d receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00360.2009
– start-page: 106335
  volume-title: J Steroid Biochem Mol Biol
  year: 2022
  ident: B68
  article-title: Genome-wide analyses of gene expression profile identify key genes and pathways involved in skeletal response to phosphate and 1,25-dihydroxyvitamin D3 in vivo
– volume: 381
  year: 2000
  ident: B26
  article-title: Regulation of the procine 1,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 and parathyroid hormone in AOK-B50 cells
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.2000.1964
– volume: 246
  year: 1984
  ident: B28
  article-title: Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation
  publication-title: Am J Physiol
  doi: 10.1152/ajpendo.1984.246.2.E168
– year: 2002
  ident: B48
  article-title: Vitamin d analogues for secondary hyperparathyroidism
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/17.suppl_10.10
– volume: 160
  year: 2019
  ident: B60
  article-title: A control region near the fibroblast growth factor 23 gene mediates response to phosphate, 1,25(OH)2D3, and LPS In vivo
  publication-title: Endocrinology
  doi: 10.1210/en.2019-00622
– volume: 13
  year: 2012
  ident: B22
  article-title: An encyclopedia of mouse DNA elements (Mouse ENCODE)
  publication-title: Genome Biol
  doi: 10.1186/gb-2012-13-8-418
– volume: 289
  year: 2005
  ident: B31
  article-title: Vitamin d receptor-independent FGF23 actions in regulating phosphate and vitamin d metabolism
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00474.2004
– volume: 121
  year: 2010
  ident: B5
  article-title: Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin d hormone
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2010.02.011
– volume: 11
  start-page: 197
  year: 2018
  ident: B64
  article-title: Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2
  publication-title: Mol Metab
  doi: 10.1016/j.molmet.2018.02.007
– volume: 5
  year: 2021
  ident: B15
  article-title: Vitamin d receptor mediates a myriad of biological actions dependent on its 1,25-dihydroxyvitamin d ligand: distinct regulatory themes revealed by induction of klotho and fibroblast growth factor-23
  publication-title: JBMR Plus
  doi: 10.1002/jbm4.10432
– volume: 9
  year: 2010
  ident: B46
  article-title: Vitamin d, disease and therapeutic opportunities
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3318
– volume: 285
  year: 2010
  ident: B41
  article-title: A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.119958
– volume: 294
  year: 2019
  ident: B21
  article-title: Targeted genomic deletions identify diverse enhancer functions and generate a kidney-specific, endocrine-deficient Cyp27b1 pseudo-null mouse
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA119.008760
– volume: 289
  year: 2014
  ident: B9
  article-title: Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M114.578104
– volume: 8
  year: 2013
  ident: B36
  article-title: FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues
  publication-title: PloS One
  doi: 10.1371/journal.pone.0072816
– volume: 81
  year: 2015
  ident: B67
  article-title: Epigenetic histone modifications and master regulators as determinants of context dependent nuclear receptor activity in bone cells
  publication-title: Bone
  doi: 10.1016/j.bone.2015.03.012
– volume: 20
  year: 2005
  ident: B45
  article-title: Identification and characterization of cis-acting elements in the human and bovine PTH mRNA 3'-untranslated region
  publication-title: J Bone Miner Res
  doi: 10.1359/JBMR.041227
– volume: 226
  year: 2015
  ident: B57
  article-title: FGF23 gene regulation by 1,25-dihydroxyvitamin d: opposing effects in adipocytes and osteocytes
  publication-title: J Endocrinol
  doi: 10.1530/JOE-15-0225
– volume: 130
  year: 2020
  ident: B61
  article-title: Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney
  publication-title: J Clin Invest
  doi: 10.1172/JCI131190
– volume: 103
  year: 2007
  ident: B11
  article-title: Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2006.12.020
– volume: 81
  year: 2001
  ident: B53
  article-title: Extracellular calcium sensing and extracellular calcium signaling
  publication-title: Physiol Rev
  doi: 10.1152/physrev.2001.81.1.239
– volume: 164
  year: 2016
  ident: B14
  article-title: Selective regulation of Mmp13 by 1,25(OH)
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2015.09.001
– volume: 39
  year: 2019
  ident: B32
  article-title: CREB promotes beta cell gene expression by targeting its coactivators to tissue-specific enhancers
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00200-19
– volume: 5
  year: 2021
  ident: B2
  article-title: Genomic mechanisms governing mineral homeostasis and the regulation and maintenance of vitamin d metabolism
  publication-title: JBMR Plus
  doi: 10.1002/jbm4.10433
– volume: 133
  year: 2023
  ident: B23
  article-title: A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin d activation and organismal calcium homeostasis
  publication-title: J Clin Invest
  doi: 10.1172/JCI163627
– volume: 271
  year: 1996
  ident: B38
  article-title: Functional assessment of two vitamin d-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.48.30381
– volume: 489
  start-page: 75
  year: 2012
  ident: B3
  article-title: The accessible chromatin landscape of the human genome
  publication-title: Nature
  doi: 10.1038/nature11232
– volume: 34
  year: 2019
  ident: B63
  article-title: PiT1/Slc20a1 is required for endoplasmic reticulum homeostasis, chondrocyte survival, and skeletal development
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.3609
– volume: 28
  year: 2013
  ident: B34
  article-title: Fibroblast growth factor-23: what we know, what we don't know, and what we need to know
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft065
– volume: 292
  year: 2017
  ident: B19
  article-title: A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D3 activation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M117.806901
– volume: 78
  year: 1986
  ident: B44
  article-title: Regulation by vitamin d metabolites of parathyroid hormone gene transcription in vivo in the rat
  publication-title: J Clin Invest
  doi: 10.1172/JCI112714
– start-page: 5
  year: 2014
  ident: B6
  article-title: Fundamentals of vitamin d hormone-regulated gene expression
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2013.11.004
SSID ssj0000401998
Score 2.3281412
SecondaryResourceType review_article
Snippet The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ). Early research...
The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D (1,25(OH) D ). Early research efforts...
The regulation of mineral homeostasis involves the three mineralotropic hormones PTH, FGF23 and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). Early research efforts...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1213361
SubjectTerms 25-Hydroxyvitamin D3 1-alpha-Hydroxylase - genetics
Calcitriol - metabolism
Calcium - metabolism
ChIP-seq analysis
CRISPR/Cas9
Cyp27b1/Cyp24a1 genes
Endocrinology
Humans
Kidney - metabolism
mineral regulating hormones
mutant mice
Parathyroid Hormone - metabolism
transcription
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bS8MwFA6yB_FFvFtvVPBNimmTXvIkKo4hzCcHewtJeoIDbcfW_X9P0m5sIvriU0uTkHByOd_XJN8h5MY6P5ZlOlJJARFPwEYCUhsVSjP0Dikr_a-B4Ws2GPGXcTpeC_XlzoS18sCt4e6o4bjQJhkWotyIWDtME2e5LXMl4tIrgVJB18iUX4ORNiCRaG_JIAsTdxaq0l32S5gTVGAsizc8kRfs_wllfj8sueZ9-ntkt4ON4UPb3H2yBdUB2R52G-OH5H64DHMbTqq5I9xzfGnq8HPiZaXrZlZPJyZ8R4haV-DSYBbN2kD02DVHZNR_fnsaRF1shMggoW0iJQBUotM04QY5gUFaAxqfTBUq00aAprllRkHpFK1iVWrFoaSFsujBS8HYMelVWN8pCbUFhG04uTU-tRVFrpHEodu3eQxU84DESztJ0wmHu_gVHxIJhLOt9LaVzrays21Abldlpq1sxq-5H535Vzmd5LX_gANBdgNB_jUQAnK97DyJU8Tte6gK6sVcIoIqEgRKNA3ISduZq6pYjniQizwgxUY3b7RlM6WavHsZ7pgyxpE_n_1H68_JjrOIO4SW5Bek18wWcIlwp9FXfmR_Ac94_GM
  priority: 102
  providerName: Directory of Open Access Journals
Title Molecular insights into mineralotropic hormone inter-regulation
URI https://www.ncbi.nlm.nih.gov/pubmed/37441497
https://www.proquest.com/docview/2838243105
https://pubmed.ncbi.nlm.nih.gov/PMC10334211
https://doaj.org/article/0c4341263d004c91b0099167fd7a91d4
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqIiEuiPJcKFWQuCFD_MjDh6oCRKmQlhMr7c2ynTFdqU1KNpXg33fGya5YVJC4xEnsxM7YznyfHzOMvY6kx8rScydr4FpC5AaKyGvnFWqHQjVpaGD-tTxb6C_LYrnHNu6OJgGub6V25E9q0V-8_fnj1wl2-GNinKhv30VoG9rHJxXZSlCK2NCdNF9ES_kmuJ_-zEgmTHKPK8pSc4nYYNxH85fX7OiqZNL_Nhz653LK3_TT6QN2fwKW2fuxJRywPWgfsrvzaer8ETuZbxzhZqt2TZR8jSdDl12ukuHpbui7q1XIzhHEdi1QHPS8H13VY-U9ZovTT98-nvHJewIPSHkH7gyAk74opA7IGgISH_AYKle70gcDPq-iCg4asnklXOOdhiavXUQd3xilnrD9FvN7xjIfAYEddn-PoY-mrjzSPAQGsRKQez1jYiMnGybT4uTh4sIixSDZ2iRbS7K1k2xn7M32mavRsMY_U38g8W9TklHsdKPrv9upj9k8aNTJssT2letghCf4K8oqNpUzosFivtpUnsVORDMjroXuem0RY9USoVRezNjTsTK3WakKEaM21YzVO9W8U5bdmHZ1ngx1i1wpjQz7-X996wt2jy5pPZqsDtn-0F_DS0Q-gz9KIwZ4_LwUR6lp3wDReAGU
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+insights+into+mineralotropic+hormone+inter-regulation&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Pike%2C+J.+Wesley&rft.au=Lee%2C+Seong+Min&rft.au=Meyer%2C+Mark+B.&rft.date=2023-06-27&rft.issn=1664-2392&rft.eissn=1664-2392&rft.volume=14&rft_id=info:doi/10.3389%2Ffendo.2023.1213361&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fendo_2023_1213361
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon